维普期刊资源整合服务平台（V6.5）

64篇 您的检索式：作者名="St clair EW"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	CTLA4Ig: Bridging the basic immunology with clinical application 显示文摘	Bluestone JA St Clair EW Turka LA	2006	Immunity2006，24，3：	1
2	Infliximab treatment for rheumatic disease: clinical and radiological efficacy显示文摘	St Clair EW	2002	Ann Rheum Dis2002，61，2：	1
3	Hepatitis C virus-related cryoglobulinemic vas-culitis:emerging trends in therapy显示文摘	St Clair EW		0，，03：	1
4	Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies显示文摘	Haynes BF Fleming J St Clair EW	2005	Science2005，308，5730：	1
5	Infliximab (chimeric anti-tumor necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomized phase Ⅲ trail 显示文摘	Maini R St Clair EW Breedveld F	1999	Lancet1999，354，9194：	1
6	Combination of infliximab and methotrexate therapy for early rheumatoid arthrtis : a randomized, controlled trial 显示文摘	St clair EW van der Heijde DM Smolen JS	2004	Arthrtis Rheum2004，50，11：	1
7	Infliximab and methotrexate in the treatment of rheumatoid arthritis 显示文摘	Lipsky PE van der Heijde DM St Clair EW	2000	N Engl J Med2000，343，22：	1
8	B cell directed therapies for autoimmune disease and correlates of disease response and relapse显示文摘	Levesque MC Clair EW St	2008	J Allergy Clin Immunol2008，1，：	1
9	Combination of infliximab and methotrexate therapy for early rheumatoid arthritis : a randomized, controlled trial 显示文摘	St Clair EW van der I-Ieijde DM Smolen JS	2004	Arthritis Rheum2004，50，11：	1
10	Infliximab (chimeric anti-tumor necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase Ⅲ trial 显示文摘	MAIN1 R ST CLAIR EW BREEDVELD F	1999	Lancet1999，354，9194：	1
11	Infliximab (chimeric anti-tumour necrosis factor c monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial 显示文摘	Maini R St Clair EW Breedveld F	1999	The Lancet1999，354，9194：	1
12	Sociodemographic associations with early disease damage in patientswith systemic lupus erythematosus显示文摘	Cooper GS Treadwell EL St Clair EW		0，，06：	1
13	Progress in the trealrnent of rheumatoid arthritis显示文摘	Pisetsky DS St Clair EW	2001	JAMA2001，286，：	1
14	Infliximab and methotrexate in the treatment of rhenmatoid arthritis显示文摘	Lipsky PE Van der Heijide DMFM St Clair EW	2000	N Engl J Med2000，343，：	1
15	Progress in the treatment of rheumatoid arthritis显示文摘	St Clair EW	2001	JAMA2001，286，：	1
16	Infliximab and methotrexate in the treatment of rheumatoid arthritis显示文摘	Lipsky PE van der Heijde DMFM St Clair EW		0，，：	1
17	Lack of correlation between serum soluble Fas/APO - 1 levels and autoimmune disease显示文摘	Goel N Ulrich DT St Clair EW	1995	Arthritis Rheum1995，38，12：	1
18	Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies 显示文摘	HAYNES BF FLEMING J ST CLAIR EW	2005	Science2005，308，：	1
19	Infliximab and methotrexate in the treatment of rheumatoid arthritis 显示文摘	Lipsky PE van der Heijde DMFM St Clair EW	2000	N Engl J Med2000，343，：	1
20	Rituximab therapy for primary Sj? gren 's syndrome: an open-label clinical trial and mechanistic analysis 显示文摘	St Clair EW Levesque MC Prak ET	2013	Arthritis Rheum2013，65，4：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示